nodes	percent_of_prediction	percent_of_DWPC	metapath
Rosiglitazone—PPARG—malignant glioma	0.461	0.575	CbGaD
Rosiglitazone—PTGS1—malignant glioma	0.34	0.425	CbGaD
Rosiglitazone—CYP1A2—Carmustine—malignant glioma	0.0504	1	CbGbCtD
Rosiglitazone—Chloropyramine—PTK2—malignant glioma	0.0049	0.59	CrCbGaD
Rosiglitazone—Pioglitazone—PPARG—malignant glioma	0.00196	0.236	CrCbGaD
Rosiglitazone—Visual acuity reduced—Temozolomide—malignant glioma	0.00168	0.0582	CcSEcCtD
Rosiglitazone—Pioglitazone—PTGS1—malignant glioma	0.00145	0.174	CrCbGaD
Rosiglitazone—ACSL4—retina—malignant glioma	0.00124	0.098	CbGeAlD
Rosiglitazone—PPARG—endothelium—malignant glioma	0.00115	0.0907	CbGeAlD
Rosiglitazone—Hyperbilirubinaemia—Temozolomide—malignant glioma	0.0011	0.0381	CcSEcCtD
Rosiglitazone—PPARG—blood vessel—malignant glioma	0.00106	0.0836	CbGeAlD
Rosiglitazone—Hepatic enzyme increased—Temozolomide—malignant glioma	0.00106	0.0366	CcSEcCtD
Rosiglitazone—ACSL4—medulla oblongata—malignant glioma	0.000898	0.0709	CbGeAlD
Rosiglitazone—Diabetes mellitus—Carmustine—malignant glioma	0.000865	0.0299	CcSEcCtD
Rosiglitazone—ACSL4—midbrain—malignant glioma	0.00082	0.0648	CbGeAlD
Rosiglitazone—Hepatic failure—Temozolomide—malignant glioma	0.000809	0.028	CcSEcCtD
Rosiglitazone—ACSL4—spinal cord—malignant glioma	0.0008	0.0632	CbGeAlD
Rosiglitazone—ACSL4—central nervous system—malignant glioma	0.000649	0.0513	CbGeAlD
Rosiglitazone—ACSL4—cerebellum—malignant glioma	0.000635	0.0501	CbGeAlD
Rosiglitazone—PPARG—embryo—malignant glioma	0.000632	0.0499	CbGeAlD
Rosiglitazone—PTGS1—endothelium—malignant glioma	0.000614	0.0485	CbGeAlD
Rosiglitazone—Hyperglycaemia—Carmustine—malignant glioma	0.000586	0.0203	CcSEcCtD
Rosiglitazone—Upper respiratory tract infection—Temozolomide—malignant glioma	0.000584	0.0202	CcSEcCtD
Rosiglitazone—Weight increased—Temozolomide—malignant glioma	0.000572	0.0198	CcSEcCtD
Rosiglitazone—Hyperglycaemia—Temozolomide—malignant glioma	0.000567	0.0196	CcSEcCtD
Rosiglitazone—PTGS1—blood vessel—malignant glioma	0.000566	0.0447	CbGeAlD
Rosiglitazone—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.000555	0.0192	CcSEcCtD
Rosiglitazone—Hepatobiliary disease—Temozolomide—malignant glioma	0.00053	0.0183	CcSEcCtD
Rosiglitazone—Sinusitis—Temozolomide—malignant glioma	0.000525	0.0182	CcSEcCtD
Rosiglitazone—ACSL4—brain—malignant glioma	0.000516	0.0407	CbGeAlD
Rosiglitazone—Oedema peripheral—Carmustine—malignant glioma	0.000512	0.0177	CcSEcCtD
Rosiglitazone—Connective tissue disorder—Carmustine—malignant glioma	0.000511	0.0177	CcSEcCtD
Rosiglitazone—Hepatitis—Temozolomide—malignant glioma	0.000503	0.0174	CcSEcCtD
Rosiglitazone—Oedema peripheral—Temozolomide—malignant glioma	0.000495	0.0171	CcSEcCtD
Rosiglitazone—Connective tissue disorder—Temozolomide—malignant glioma	0.000494	0.0171	CcSEcCtD
Rosiglitazone—Eye disorder—Carmustine—malignant glioma	0.000486	0.0168	CcSEcCtD
Rosiglitazone—Erythema multiforme—Temozolomide—malignant glioma	0.000475	0.0164	CcSEcCtD
Rosiglitazone—Eye disorder—Temozolomide—malignant glioma	0.00047	0.0163	CcSEcCtD
Rosiglitazone—Cardiac disorder—Temozolomide—malignant glioma	0.000467	0.0161	CcSEcCtD
Rosiglitazone—Immune system disorder—Temozolomide—malignant glioma	0.000454	0.0157	CcSEcCtD
Rosiglitazone—Malnutrition—Carmustine—malignant glioma	0.000453	0.0157	CcSEcCtD
Rosiglitazone—Back pain—Carmustine—malignant glioma	0.000438	0.0152	CcSEcCtD
Rosiglitazone—Malnutrition—Temozolomide—malignant glioma	0.000438	0.0151	CcSEcCtD
Rosiglitazone—Back pain—Temozolomide—malignant glioma	0.000423	0.0146	CcSEcCtD
Rosiglitazone—Anaemia—Carmustine—malignant glioma	0.000419	0.0145	CcSEcCtD
Rosiglitazone—Leukopenia—Carmustine—malignant glioma	0.000405	0.014	CcSEcCtD
Rosiglitazone—Anaemia—Temozolomide—malignant glioma	0.000404	0.014	CcSEcCtD
Rosiglitazone—Angioedema—Temozolomide—malignant glioma	0.0004	0.0138	CcSEcCtD
Rosiglitazone—Leukopenia—Temozolomide—malignant glioma	0.000392	0.0136	CcSEcCtD
Rosiglitazone—Hypertension—Carmustine—malignant glioma	0.000391	0.0135	CcSEcCtD
Rosiglitazone—Myalgia—Carmustine—malignant glioma	0.000386	0.0133	CcSEcCtD
Rosiglitazone—Hypertension—Temozolomide—malignant glioma	0.000378	0.0131	CcSEcCtD
Rosiglitazone—Myalgia—Temozolomide—malignant glioma	0.000373	0.0129	CcSEcCtD
Rosiglitazone—Arthralgia—Temozolomide—malignant glioma	0.000373	0.0129	CcSEcCtD
Rosiglitazone—Oedema—Carmustine—malignant glioma	0.00037	0.0128	CcSEcCtD
Rosiglitazone—Infection—Carmustine—malignant glioma	0.000367	0.0127	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Carmustine—malignant glioma	0.000362	0.0125	CcSEcCtD
Rosiglitazone—Oedema—Temozolomide—malignant glioma	0.000357	0.0124	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Temozolomide—malignant glioma	0.000357	0.0124	CcSEcCtD
Rosiglitazone—Infection—Temozolomide—malignant glioma	0.000355	0.0123	CcSEcCtD
Rosiglitazone—Nervous system disorder—Temozolomide—malignant glioma	0.00035	0.0121	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Temozolomide—malignant glioma	0.00035	0.0121	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000337	0.0117	CcSEcCtD
Rosiglitazone—CYP2A6—cerebellum—malignant glioma	0.000335	0.0265	CbGeAlD
Rosiglitazone—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000325	0.0113	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Carmustine—malignant glioma	0.000319	0.011	CcSEcCtD
Rosiglitazone—Constipation—Carmustine—malignant glioma	0.000316	0.0109	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000308	0.0107	CcSEcCtD
Rosiglitazone—Fatigue—Temozolomide—malignant glioma	0.000308	0.0107	CcSEcCtD
Rosiglitazone—Constipation—Temozolomide—malignant glioma	0.000305	0.0106	CcSEcCtD
Rosiglitazone—PPARG—central nervous system—malignant glioma	0.000292	0.0231	CbGeAlD
Rosiglitazone—Urticaria—Temozolomide—malignant glioma	0.000284	0.00982	CcSEcCtD
Rosiglitazone—PTGS1—telencephalon—malignant glioma	0.000275	0.0217	CbGeAlD
Rosiglitazone—CYP2A6—brain—malignant glioma	0.000272	0.0215	CbGeAlD
Rosiglitazone—Asthenia—Carmustine—malignant glioma	0.000265	0.00918	CcSEcCtD
Rosiglitazone—Asthenia—Temozolomide—malignant glioma	0.000256	0.00887	CcSEcCtD
Rosiglitazone—CYP2D6—brainstem—malignant glioma	0.000254	0.0201	CbGeAlD
Rosiglitazone—Diarrhoea—Carmustine—malignant glioma	0.000253	0.00875	CcSEcCtD
Rosiglitazone—Pruritus—Temozolomide—malignant glioma	0.000253	0.00874	CcSEcCtD
Rosiglitazone—Dizziness—Carmustine—malignant glioma	0.000244	0.00846	CcSEcCtD
Rosiglitazone—Diarrhoea—Temozolomide—malignant glioma	0.000244	0.00846	CcSEcCtD
Rosiglitazone—Dizziness—Temozolomide—malignant glioma	0.000236	0.00817	CcSEcCtD
Rosiglitazone—Rash—Carmustine—malignant glioma	0.000233	0.00806	CcSEcCtD
Rosiglitazone—Dermatitis—Carmustine—malignant glioma	0.000233	0.00806	CcSEcCtD
Rosiglitazone—PPARG—brain—malignant glioma	0.000232	0.0183	CbGeAlD
Rosiglitazone—Headache—Carmustine—malignant glioma	0.000232	0.00801	CcSEcCtD
Rosiglitazone—CYP2D6—telencephalon—malignant glioma	0.000226	0.0178	CbGeAlD
Rosiglitazone—Rash—Temozolomide—malignant glioma	0.000225	0.00779	CcSEcCtD
Rosiglitazone—Dermatitis—Temozolomide—malignant glioma	0.000225	0.00779	CcSEcCtD
Rosiglitazone—Headache—Temozolomide—malignant glioma	0.000224	0.00774	CcSEcCtD
Rosiglitazone—Nausea—Carmustine—malignant glioma	0.00022	0.0076	CcSEcCtD
Rosiglitazone—ALB—brain—malignant glioma	0.000218	0.0172	CbGeAlD
Rosiglitazone—Nausea—Temozolomide—malignant glioma	0.000212	0.00734	CcSEcCtD
Rosiglitazone—PTGS1—spinal cord—malignant glioma	0.000193	0.0152	CbGeAlD
Rosiglitazone—PTGS1—central nervous system—malignant glioma	0.000156	0.0123	CbGeAlD
Rosiglitazone—CYP2C8—brain—malignant glioma	0.000153	0.0121	CbGeAlD
Rosiglitazone—CYP2D6—central nervous system—malignant glioma	0.000128	0.0101	CbGeAlD
Rosiglitazone—CYP2D6—cerebellum—malignant glioma	0.000125	0.0099	CbGeAlD
Rosiglitazone—PTGS1—brain—malignant glioma	0.000124	0.00979	CbGeAlD
Rosiglitazone—CYP2D6—brain—malignant glioma	0.000102	0.00804	CbGeAlD
Rosiglitazone—CYP2A6—Metabolism—PTGS1—malignant glioma	2.12e-05	0.000215	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	2.1e-05	0.000213	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—IDH2—malignant glioma	2.09e-05	0.000212	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—BCHE—malignant glioma	2.08e-05	0.000211	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—TNF—malignant glioma	2.08e-05	0.000211	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—VEGFA—malignant glioma	2.08e-05	0.000211	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—PDGFB—malignant glioma	2.07e-05	0.000211	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—KRAS—malignant glioma	2.06e-05	0.000209	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—SLC5A5—malignant glioma	2.06e-05	0.000209	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—BCAN—malignant glioma	2.02e-05	0.000205	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—IDH1—malignant glioma	2.01e-05	0.000204	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—AKT1—malignant glioma	2.01e-05	0.000204	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—IDH1—malignant glioma	2e-05	0.000203	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	1.97e-05	0.0002	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—BCHE—malignant glioma	1.97e-05	0.0002	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—CAV1—malignant glioma	1.96e-05	0.0002	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CYP2B6—malignant glioma	1.96e-05	0.0002	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—SPHK1—malignant glioma	1.95e-05	0.000198	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.94e-05	0.000197	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—SLC5A5—malignant glioma	1.94e-05	0.000197	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—SPHK1—malignant glioma	1.94e-05	0.000197	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.93e-05	0.000196	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—IDH2—malignant glioma	1.92e-05	0.000195	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—CYP2C18—malignant glioma	1.91e-05	0.000194	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—IDH2—malignant glioma	1.9e-05	0.000194	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—CYP2C18—malignant glioma	1.9e-05	0.000193	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.89e-05	0.000192	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—FN1—malignant glioma	1.87e-05	0.00019	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—F2—malignant glioma	1.87e-05	0.00019	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—GSTP1—malignant glioma	1.86e-05	0.000189	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—CAT—malignant glioma	1.81e-05	0.000184	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CYP2B6—malignant glioma	1.81e-05	0.000184	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.8e-05	0.000183	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—IDH1—malignant glioma	1.8e-05	0.000183	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	1.8e-05	0.000182	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CYP2B6—malignant glioma	1.79e-05	0.000182	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—PIK3CG—malignant glioma	1.79e-05	0.000182	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.79e-05	0.000182	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—CAV1—malignant glioma	1.77e-05	0.00018	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—EGF—malignant glioma	1.77e-05	0.00018	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—PTPN11—malignant glioma	1.76e-05	0.000179	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—SPHK1—malignant glioma	1.74e-05	0.000177	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—NCOR1—malignant glioma	1.71e-05	0.000174	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CYP2C18—malignant glioma	1.7e-05	0.000173	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.69e-05	0.000172	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.68e-05	0.000171	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—GSTP1—malignant glioma	1.66e-05	0.000168	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—IDH1—malignant glioma	1.65e-05	0.000168	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.64e-05	0.000166	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—IDH1—malignant glioma	1.64e-05	0.000166	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—AKT2—malignant glioma	1.64e-05	0.000166	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.63e-05	0.000166	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—IDH2—malignant glioma	1.63e-05	0.000165	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—PIK3CA—malignant glioma	1.62e-05	0.000165	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—PIK3CG—malignant glioma	1.61e-05	0.000164	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—CAT—malignant glioma	1.61e-05	0.000164	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.61e-05	0.000163	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—SPHK1—malignant glioma	1.6e-05	0.000162	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—SPHK1—malignant glioma	1.58e-05	0.000161	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.58e-05	0.000161	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—PIK3CD—malignant glioma	1.57e-05	0.00016	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.57e-05	0.00016	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CYP2C18—malignant glioma	1.57e-05	0.000159	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—GSTP1—malignant glioma	1.57e-05	0.000159	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CYP2C18—malignant glioma	1.55e-05	0.000158	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—AKT1—malignant glioma	1.55e-05	0.000157	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—GSTT1—malignant glioma	1.54e-05	0.000157	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	1.53e-05	0.000156	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—GSTT1—malignant glioma	1.53e-05	0.000156	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CYP2B6—malignant glioma	1.53e-05	0.000155	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—CAT—malignant glioma	1.52e-05	0.000155	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—NCOR1—malignant glioma	1.52e-05	0.000155	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.46e-05	0.000149	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.46e-05	0.000149	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PTGS1—malignant glioma	1.45e-05	0.000147	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.44e-05	0.000146	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—NCOR1—malignant glioma	1.44e-05	0.000146	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PTGS1—malignant glioma	1.44e-05	0.000146	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.43e-05	0.000146	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—PIK3CD—malignant glioma	1.42e-05	0.000144	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.41e-05	0.000143	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—RAF1—malignant glioma	1.4e-05	0.000143	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—IDH1—malignant glioma	1.4e-05	0.000142	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—CAV1—malignant glioma	1.39e-05	0.000142	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—GSTT1—malignant glioma	1.38e-05	0.00014	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—PIK3CB—malignant glioma	1.37e-05	0.000139	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—SPHK1—malignant glioma	1.35e-05	0.000138	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—BCHE—malignant glioma	1.34e-05	0.000137	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—BCHE—malignant glioma	1.34e-05	0.000136	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.33e-05	0.000135	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.33e-05	0.000135	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—SLC5A5—malignant glioma	1.33e-05	0.000135	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CYP2C18—malignant glioma	1.33e-05	0.000135	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—AKT1—malignant glioma	1.32e-05	0.000135	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—SLC5A5—malignant glioma	1.32e-05	0.000134	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PTGS1—malignant glioma	1.29e-05	0.000131	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.29e-05	0.000131	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.29e-05	0.000131	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PIK3CG—malignant glioma	1.27e-05	0.000129	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GSTT1—malignant glioma	1.27e-05	0.000129	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—IL2—malignant glioma	1.26e-05	0.000128	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GSTT1—malignant glioma	1.26e-05	0.000128	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.26e-05	0.000128	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.25e-05	0.000127	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.25e-05	0.000127	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.24e-05	0.000126	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—CAV1—malignant glioma	1.24e-05	0.000126	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.24e-05	0.000126	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—PIK3CB—malignant glioma	1.24e-05	0.000126	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PPARG—malignant glioma	1.23e-05	0.000125	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—PTGS2—malignant glioma	1.22e-05	0.000124	CbGpPWpGaD
Rosiglitazone—ALB—Transmembrane transport of small molecules—RAF1—malignant glioma	1.22e-05	0.000124	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—BCHE—malignant glioma	1.2e-05	0.000122	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PTGS1—malignant glioma	1.19e-05	0.000121	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—SLC5A5—malignant glioma	1.18e-05	0.00012	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.18e-05	0.00012	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PTGS1—malignant glioma	1.18e-05	0.00012	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—CAV1—malignant glioma	1.17e-05	0.000119	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.17e-05	0.000119	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—MYC—malignant glioma	1.14e-05	0.000116	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.14e-05	0.000116	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PIK3CG—malignant glioma	1.13e-05	0.000115	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.12e-05	0.000114	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PIK3CD—malignant glioma	1.12e-05	0.000113	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.11e-05	0.000113	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—BCHE—malignant glioma	1.1e-05	0.000112	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.1e-05	0.000112	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—BCHE—malignant glioma	1.09e-05	0.000111	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PPARG—malignant glioma	1.09e-05	0.000111	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—SLC5A5—malignant glioma	1.09e-05	0.000111	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.08e-05	0.00011	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—SLC5A5—malignant glioma	1.08e-05	0.00011	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.08e-05	0.00011	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GSTT1—malignant glioma	1.07e-05	0.000109	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—VEGFA—malignant glioma	1.07e-05	0.000109	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—GSTP1—malignant glioma	1.07e-05	0.000109	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PIK3CG—malignant glioma	1.07e-05	0.000109	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—PTEN—malignant glioma	1.07e-05	0.000108	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—GSTP1—malignant glioma	1.06e-05	0.000108	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—CAT—malignant glioma	1.04e-05	0.000106	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—CAT—malignant glioma	1.03e-05	0.000105	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PPARG—malignant glioma	1.03e-05	0.000105	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.02e-05	0.000104	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.01e-05	0.000103	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PTGS1—malignant glioma	1.01e-05	0.000102	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1e-05	0.000102	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PIK3CD—malignant glioma	9.93e-06	0.000101	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—NCOR1—malignant glioma	9.83e-06	9.99e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—NCOR1—malignant glioma	9.77e-06	9.93e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PIK3CB—malignant glioma	9.73e-06	9.89e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	9.68e-06	9.84e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PTGS2—malignant glioma	9.64e-06	9.8e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—GSTP1—malignant glioma	9.55e-06	9.7e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PIK3CD—malignant glioma	9.39e-06	9.54e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—BCHE—malignant glioma	9.35e-06	9.5e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CAT—malignant glioma	9.29e-06	9.44e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—SLC5A5—malignant glioma	9.23e-06	9.38e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—KRAS—malignant glioma	9.1e-06	9.24e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	8.83e-06	8.97e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GSTP1—malignant glioma	8.78e-06	8.92e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—NCOR1—malignant glioma	8.77e-06	8.91e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	8.73e-06	8.87e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GSTP1—malignant glioma	8.7e-06	8.84e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PIK3CB—malignant glioma	8.66e-06	8.8e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	8.65e-06	8.79e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PTGS2—malignant glioma	8.58e-06	8.72e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CAT—malignant glioma	8.54e-06	8.68e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CAT—malignant glioma	8.47e-06	8.61e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PTEN—malignant glioma	8.41e-06	8.54e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—PIK3CA—malignant glioma	8.36e-06	8.49e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PIK3CB—malignant glioma	8.19e-06	8.32e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PTGS2—malignant glioma	8.11e-06	8.24e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—TP53—malignant glioma	8.09e-06	8.22e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—NCOR1—malignant glioma	8.07e-06	8.2e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—CAV1—malignant glioma	8.01e-06	8.14e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—NCOR1—malignant glioma	8e-06	8.13e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—CAV1—malignant glioma	7.97e-06	8.09e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—AKT1—malignant glioma	7.91e-06	8.04e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	7.65e-06	7.78e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	7.61e-06	7.73e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	7.55e-06	7.67e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—PIK3CA—malignant glioma	7.53e-06	7.65e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PTEN—malignant glioma	7.48e-06	7.6e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GSTP1—malignant glioma	7.44e-06	7.56e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PIK3CG—malignant glioma	7.3e-06	7.41e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PIK3CG—malignant glioma	7.26e-06	7.37e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CAT—malignant glioma	7.24e-06	7.35e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CAV1—malignant glioma	7.15e-06	7.27e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PTEN—malignant glioma	7.07e-06	7.19e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PPARG—malignant glioma	7.04e-06	7.16e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PPARG—malignant glioma	7e-06	7.12e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—NCOR1—malignant glioma	6.83e-06	6.94e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	6.83e-06	6.94e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—AKT1—malignant glioma	6.83e-06	6.94e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CAV1—malignant glioma	6.58e-06	6.68e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CAV1—malignant glioma	6.52e-06	6.62e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PIK3CG—malignant glioma	6.51e-06	6.62e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PIK3CD—malignant glioma	6.41e-06	6.52e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PIK3CD—malignant glioma	6.38e-06	6.48e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PPARG—malignant glioma	6.29e-06	6.39e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	6.23e-06	6.33e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—AKT1—malignant glioma	6.15e-06	6.25e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PIK3CG—malignant glioma	5.99e-06	6.09e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PIK3CG—malignant glioma	5.94e-06	6.03e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PIK3CA—malignant glioma	5.93e-06	6.03e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PPARG—malignant glioma	5.78e-06	5.87e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PPARG—malignant glioma	5.73e-06	5.82e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PIK3CD—malignant glioma	5.73e-06	5.82e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PIK3CB—malignant glioma	5.59e-06	5.68e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CAV1—malignant glioma	5.57e-06	5.66e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PIK3CB—malignant glioma	5.56e-06	5.65e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PTGS2—malignant glioma	5.54e-06	5.63e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PTGS2—malignant glioma	5.51e-06	5.6e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	5.32e-06	5.41e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PIK3CA—malignant glioma	5.28e-06	5.36e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PIK3CD—malignant glioma	5.27e-06	5.35e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PIK3CD—malignant glioma	5.22e-06	5.3e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PIK3CG—malignant glioma	5.07e-06	5.16e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PIK3CB—malignant glioma	4.99e-06	5.07e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PIK3CA—malignant glioma	4.99e-06	5.07e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PTGS2—malignant glioma	4.95e-06	5.02e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PPARG—malignant glioma	4.9e-06	4.98e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—AKT1—malignant glioma	4.85e-06	4.92e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PTEN—malignant glioma	4.83e-06	4.91e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PTEN—malignant glioma	4.8e-06	4.88e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PIK3CB—malignant glioma	4.59e-06	4.66e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PIK3CB—malignant glioma	4.55e-06	4.62e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PTGS2—malignant glioma	4.55e-06	4.62e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PTGS2—malignant glioma	4.51e-06	4.58e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PIK3CD—malignant glioma	4.46e-06	4.53e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PTEN—malignant glioma	4.31e-06	4.38e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—AKT1—malignant glioma	4.31e-06	4.38e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—AKT1—malignant glioma	4.08e-06	4.14e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PTEN—malignant glioma	3.97e-06	4.03e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PTEN—malignant glioma	3.93e-06	4e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PIK3CB—malignant glioma	3.89e-06	3.95e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PTGS2—malignant glioma	3.85e-06	3.92e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PIK3CA—malignant glioma	3.41e-06	3.46e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PIK3CA—malignant glioma	3.39e-06	3.44e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PTEN—malignant glioma	3.36e-06	3.41e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PIK3CA—malignant glioma	3.04e-06	3.09e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PIK3CA—malignant glioma	2.8e-06	2.84e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—AKT1—malignant glioma	2.78e-06	2.83e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PIK3CA—malignant glioma	2.77e-06	2.82e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—AKT1—malignant glioma	2.77e-06	2.81e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—AKT1—malignant glioma	2.49e-06	2.53e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PIK3CA—malignant glioma	2.37e-06	2.41e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—AKT1—malignant glioma	2.29e-06	2.32e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—AKT1—malignant glioma	2.27e-06	2.3e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—AKT1—malignant glioma	1.94e-06	1.97e-05	CbGpPWpGaD
